1. Home
  2. GTBP vs DFLI Comparison

GTBP vs DFLI Comparison

Compare GTBP & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • DFLI
  • Stock Information
  • Founded
  • GTBP 1965
  • DFLI 2020
  • Country
  • GTBP United States
  • DFLI United States
  • Employees
  • GTBP N/A
  • DFLI N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • DFLI Electronic Components
  • Sector
  • GTBP Health Care
  • DFLI Technology
  • Exchange
  • GTBP Nasdaq
  • DFLI Nasdaq
  • Market Cap
  • GTBP 5.5M
  • DFLI 5.0M
  • IPO Year
  • GTBP N/A
  • DFLI N/A
  • Fundamental
  • Price
  • GTBP $1.77
  • DFLI $0.26
  • Analyst Decision
  • GTBP Strong Buy
  • DFLI Strong Buy
  • Analyst Count
  • GTBP 1
  • DFLI 1
  • Target Price
  • GTBP $11.00
  • DFLI $1.50
  • AVG Volume (30 Days)
  • GTBP 74.2K
  • DFLI 46.6M
  • Earning Date
  • GTBP 08-13-2025
  • DFLI 08-14-2025
  • Dividend Yield
  • GTBP N/A
  • DFLI N/A
  • EPS Growth
  • GTBP N/A
  • DFLI N/A
  • EPS
  • GTBP N/A
  • DFLI N/A
  • Revenue
  • GTBP N/A
  • DFLI $51,496,000.00
  • Revenue This Year
  • GTBP N/A
  • DFLI $30.09
  • Revenue Next Year
  • GTBP N/A
  • DFLI $50.08
  • P/E Ratio
  • GTBP N/A
  • DFLI N/A
  • Revenue Growth
  • GTBP N/A
  • DFLI N/A
  • 52 Week Low
  • GTBP $1.72
  • DFLI $0.15
  • 52 Week High
  • GTBP $4.10
  • DFLI $6.21
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 31.45
  • DFLI 48.32
  • Support Level
  • GTBP $2.01
  • DFLI $0.22
  • Resistance Level
  • GTBP $2.11
  • DFLI $0.27
  • Average True Range (ATR)
  • GTBP 0.14
  • DFLI 0.07
  • MACD
  • GTBP -0.01
  • DFLI -0.00
  • Stochastic Oscillator
  • GTBP 8.77
  • DFLI 20.62

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: